The Early Drug Development Center (EDDC) treatment team is comprised of a multidisciplinary group of medical oncologists, cardiologists, nephrologists, nursing staff and researchers who specialize in designing, conducting and analyzing clinical trials of experimental medicines to ensure that your treatment is closely monitored and safe. In addition, the EDDC targets disease-specific malignancies by collaborating with Dana-Farber clinicians across all treatment centers who are dedicated to improving your care with their expertise.
Early Drug Development Center Clinicians
Geoffrey Shapiro, MD, PhD, Disease Center Leader
Khanh Do, MD, Clinical Director
Andrew Wolanski, NP
Disease Center Collaborators
Elizabeth Buchbinder, MD, Melanoma Cancer Treatment Center
Atish Choudhury, MD, PhD, Genitourinary Treatment Center
James Cleary, MD, PhD, Gastrointestinal Cancer Treatment Center
Rinath Jeselsohn, MD, Breast Cancer Treatment Center
Sara Tolaney, MD, Breast Cancer Treatment Center
Research Nurses
Anne Caramella, RN, BSN
Jennifer Hedglin, RN, BSN
Danielle Nunziato, RN, BSN
Rachel Patchel, RN, BSN
Allison Powers, RN, BSN
Nicholas Quinn, RN, BSN
Clinical Research Manager
Ketki Bhushan, MPH
Regulatory Coordinators
Elizabeth Downey
Solida Pruitt-Thompson
Allison Valencia
Senior Clinical Research Coordinators
Illy Dixon
Matt Milstein
Clinical Research Coordinators
Philip Chieng
Sarah Desmarais
Courtney Gannon
Sienna Kardel
Sarah Kelland
Loan Vuong